首页> 外文期刊>Pediatric emergency care >Damage control resuscitation: permissive hypotension and massive transfusion protocols.
【24h】

Damage control resuscitation: permissive hypotension and massive transfusion protocols.

机译:损伤控制复苏:允许性低血压和大量输血方案。

获取原文
获取原文并翻译 | 示例
           

摘要

Evidence for changes in adult trauma management often precedes evidence for changes in pediatric trauma management. Many adult trauma centers have adopted damage-control resuscitation management strategies, which target the metabolic syndrome of acidosis, coagulopathy, and hypothermia often found in severe uncontrolled hemorrhage. Two key components of damage-control resuscitation are permissive hypotension, which is a fluid management strategy that targets a subnormal blood pressure, and hemostatic resuscitation, which is a transfusion strategy that targets coagulopathy with early blood product administration. Acceptance of damage-control resuscitation strategies is reflected in recent changes in the American College of Surgeons' Advanced Trauma Life Support curriculum; the most recent edition has decreased its initial fluid recommendation to 1 L from 2 L, and it now recommends early administration of blood products without specifying any specific ratio. These recommendations are not advocating permissive hypotension or hemostatic resuscitation directly but represent an initial step toward limiting fluid resuscitation and using blood products to treat coagulopathy earlier. Evidence for permissive hypotension exists in animal studies and few adult clinical trials. There is no evidence to support permissive hypotension strategies in pediatrics. Evidence for hemostatic resuscitation in adult trauma management is more comprehensive, and there are limited data to support its use in pediatric trauma patients with severe hemorrhage. Additional studies on the management of children with severe uncontrolled hemorrhage are needed.
机译:成人创伤管理改变的证据通常先于小儿创伤管理改变的证据。许多成人创伤中心已采取了损害控制复苏管理策略,该策略针对的是酸中毒,凝血病和体温过低的代谢综合征,这些综合征常在严重的失控性出血中发现。损害控制复苏的两个关键组成部分是允许性低血压和止血复苏,后者是针对血压低于正常血压的液体管理策略,而止血复苏是针对早期血液制品给药引起的凝血病的输血策略。美国外科医师学会高级创伤生命支持课程的最新变化反映了对损害控制复苏策略的接受。最新版本已将其初始液体推荐量从2 L降低至1 L,现在建议不指定任何特定比例就尽早使用血液制品。这些建议并非直接倡导低血压或止血复苏,而是朝着限制液体复苏和使用血液制品更早地治疗凝血病迈出的第一步。在动物研究和成人临床试验中都存在允许性低血压的证据。没有证据支持小儿允许的低血压策略。在成人创伤治疗中进行止血复苏的证据更为全面,并且仅有有限的数据支持其在严重出血的小儿创伤患者中的使用。需要对严重失控出血儿童的治疗进行其他研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号